IBM is one of the most complex and commercially aggressive enterprise software vendors to negotiate with. PVU-based licensing, ILMT compliance requirements, ELA and ELC structures, sub-capacity entitlements, audit programs, and increasingly aggressive Cloud and Red Hat bundling all create a commercial environment where enterprises without specialist expertise consistently overpay. Redress Compliance provides independent IBM advisory — backed by 200-plus years of collective IBM licensing experience — with no IBM partnership, no IBM reseller relationship, and no conflict of interest.
IBM's commercial organization operates with a structural advantage in every enterprise negotiation. Its account teams have access to pricing analytics across comparable transactions in your sector, your geography, and your deal size. They know IBM's pricing floor on every product. They know which audit findings enterprises typically contest and which they accept. And they operate from a position of deep IBM licensing expertise that most enterprise procurement teams cannot match without specialist support.
The result is a consistent pattern: enterprises overpay on ELA renewals, accept inflated audit claims, miss sub-capacity licensing opportunities, and carry IBM license sprawl that nobody has independently reviewed. Redress Compliance addresses every one of these scenarios. Our team includes former IBM licensing specialists who know IBM's methodologies, tactics, and pricing from the inside — combined with the independence to use that knowledge exclusively in your interests.
We do not resell IBM licenses. We have no IBM partnership. Every recommendation is built to reduce your IBM costs and strengthen your commercial position.
IBM license sprawl is endemic. PVU over-allocation across virtualized environments, ILMT non-compliance creating full-capacity exposure, sub-capacity entitlements that aren't being used, and shelfware from acquisitions all represent avoidable cost and compliance risk. We conduct a comprehensive assessment of your IBM estate and identify every savings and risk remediation opportunity.
IBM's Software Audit Services program is one of the most technically aggressive in enterprise software. IBM auditors use ILMT data, product definition documents, and sub-capacity licensing rules in ways that consistently produce inflated compliance gaps. The data you share and the response you provide in the first 30 days determines the outcome. We take control of the full audit process — challenging IBM's methodology, disputing findings, managing data disclosure, and negotiating the settlement to its genuine level.
IBM ELA and ELC renewals are among the most commercially consequential events in any IBM-reliant enterprise's calendar. IBM's renewal proposals are constructed to maintain or grow IBM's revenue while appearing to offer significant value. Without benchmark data and independent commercial expertise, most enterprises accept terms that are materially above what comparable organizations have achieved. We provide structured ELA renewal advisory — benchmarking, strategy, and negotiation support — for every IBM ELA and ELC renewal regardless of size.
Whether you are negotiating a new ELA, renewing Passport Advantage, committing to IBM Cloud, or negotiating Red Hat subscriptions, IBM's commercial teams hold a significant information advantage over most enterprise procurement functions. We close that gap — bringing benchmark data from hundreds of comparable IBM transactions and the negotiation expertise to use it effectively. Average improvement over IBM's opening position: 20–35%.
IBM licensing is a consistent source of undisclosed M&A liability. ELA change-of-control provisions, PVU obligation transfers, ILMT compliance gaps in the target estate, and IBM Cloud commitments that don't survive ownership changes all create unexpected post-close costs for acquirers who don't conduct independent IBM due diligence. We identify every liability pre-close, manage the contract restructure through the transaction, and deliver post-close consolidation savings on the combined IBM agreement.
ILMT deployment requirements, sub-capacity licensing eligibility across different hypervisor environments, product definition boundary conditions, and the interaction between virtualization technology and IBM's licensing rules create compliance risk that most enterprises cannot independently manage. We provide ongoing compliance advisory — assessing your IBM deployment, confirming ILMT configuration, and advising on the license position across every IBM product in your estate.
We benchmark IBM's commercial terms against comparable transactions, identify the savings opportunity, and deliver a no-obligation business case with projected ROI — before you commit to anything. Most benchmarking engagements complete within two weeks and identify savings of 20–35% on IBM's current proposal.
Or call us directly: +1 (239) 402-7397
Mutual NDA before any data is shared. Confidentiality protected from the first conversation. Typically same-day.
Confidential call covering your IBM estate, renewal timeline, audit status, and the commercial pressures you face.
Share IBM ELAs, order schedules, ILMT data, and IBM proposals. Reviewed under NDA to identify every opportunity.
Detailed business case with projected savings, benchmarked pricing, and our fee — so you see the return before committing.
Engagement begins immediately with a dedicated IBM advisory team. Most clients see first measurable savings within 60 days.
No IBM partnership. No reseller margin. No conflict of interest. Every recommendation is built to reduce your IBM costs and increase your negotiating leverage.
Our team includes former IBM licensing specialists who know IBM's audit methodologies, commercial tactics, and pricing structures from the inside — combined with the independence to use that knowledge in your interests.
Our benchmark database covers hundreds of comparable IBM ELA transactions. We know what organizations in your sector have actually achieved. IBM's account team has that data — now you do too.
From ILMT compliance review and proactive license optimization to audit defense, ELA negotiation, and M&A due diligence — we cover the entire IBM commercial relationship.
Fixed-fee retainer or Pay When We Save contingency. Under contingency, we are paid only on verified savings. Our commercial interests and yours are identical from day one.
300-plus IBM engagements completed. $500M-plus in IBM spend under advisory. Consistent outcomes across license assessment, audit defense, ELA negotiation, and M&A advisory.
IBM proposed a standard ELA renewal with PVU allocation at full-capacity rates. Our assessment identified $2.8M in sub-capacity opportunities and challenged $1.4M in bundled professional services at IBM's listed rate. Final deal: $14.8M with a five-year price lock.
IBM's audit claim reached $7.4M covering PVU over-deployment and ILMT configuration non-compliance. We challenged IBM's deployment measurement methodology and applied the correct Sub-Capacity Licensing terms — settling at $1.1M, an 85% reduction from IBM's opening claim.
Comprehensive assessment identified $3.6M in over-allocated PVU licenses and ILMT configuration errors that were creating full-capacity exposure. All items remediated before IBM's audit team identified the same gaps.
IBM's opening ELA proposal was 28% above comparable recent transactions in the same sector. Benchmark data anchored a counter-position that delivered $3.9M in savings across a five-year term, including price lock provisions IBM had not initially offered.
Pre-close IBM due diligence identified $2.8M in undisclosed ELA liabilities — including a change-of-control clause that would have triggered full re-pricing at completion. Both items were reflected in the final purchase price adjustment.
Proactive ILMT review identified configuration errors across 12 IBM deployments. Remediation prevented $4.1M in potential audit exposure before IBM's Software Audit Services team conducted its scheduled review.
We cover the full IBM commercial lifecycle: license assessment (ILMT, PVU, sub-capacity analysis), audit defense (managing IBM Software Audit Services claims from initial response to final settlement), ELA and ELC renewal negotiation, contract negotiation for new deals and Passport Advantage renewals, IBM Cloud and Red Hat commercial advisory, M&A due diligence and post-close consolidation, and ongoing compliance and risk advisory.
Yes. We have no IBM partnership, no IBM reseller relationship, and no commercial tie to IBM or any IBM competitor. Our advisory team includes former IBM licensing specialists, but every recommendation we make is built exclusively to reduce your IBM costs and strengthen your commercial position. We are paid by our clients — not by IBM.
We offer fixed-fee retainer and Pay When We Save contingency structures. Under contingency, we are paid only on verified savings — our fee is a percentage of the savings we deliver. For IBM audit defense, we work entirely on contingency in most cases: if IBM's claim is not reduced, there is no advisory fee. We provide a detailed business case with projected savings and fees before any engagement begins.
We can have an engagement team operational within five business days of signing an NDA and receiving your IBM contracts and relevant data. For IBM audit situations with a pending IBM response deadline, we can mobilize within 48 hours.
Yes. IBM audit defense is one of our most common engagement scenarios. We take over the full audit management process — controlling data disclosure to IBM, challenging IBM's methodology, and negotiating the settlement. The most important step is engaging us before responding to IBM's initial audit notice, as the first 30 days of an IBM audit determine much of the final outcome.
IBM's licensing rules are genuinely complex — PVU metrics, ILMT sub-capacity eligibility across different hypervisor environments, ELA scope definitions, and IBM's audit methodology require specialist knowledge that general SAM advisors often lack. Our team includes former IBM employees who worked inside IBM's licensing, commercial, and audit functions. We know IBM's pricing floors, its audit playbook, and its commercial tactics from the inside. That depth of IBM-specific expertise — combined with complete independence from IBM — is what consistently delivers outcomes that general advisors cannot match.
Guides, benchmarks, and intelligence for every IBM commercial scenario.
7 free tools to estimate savings across licenses, audits, and ELA negotiations.
Complete IBM audit management from initial response to final settlement.
Independent ELA negotiation support delivering better commercial outcomes.
Benchmark-backed negotiation support for IBM renewals, ELAs, and new deals.
Identify IBM license liabilities pre-close and optimize the combined estate post-close.